(αE)-α-(MethoxyiMino)-2-[(2-Methylphenoxy)Methyl]benzeneacetic Acid
![]() |
- $185 - $2200
- Product name: (αE)-α-(MethoxyiMino)-2-[(2-Methylphenoxy)Methyl]benzeneacetic Acid
- CAS: 1007364-30-8
- MF: C17H17NO4
- MW: 299.32118
- EINECS:
- MDL Number:MFCD30186605
- Synonyms:(αE)-α-(MethoxyiMino)-2-[(2-Methylphenoxy)Methyl]benzeneacetic Acid;(alphaE)-alpha-(Methoxyimino)-2-[(2-methylphenoxy)methyl]benzeneacetic acid;LXOPDEDFRXZTNO-FBMGVBCBSA-N;Kresoxim (free acid);Kresoxim-methyl acid;Benzeneacetic acid, α-(methoxyimino)-2-[(2-methylphenoxy)methyl]-, (αE)-;(αE)-α-(MethoxyiMino)-2-[(2-Methylphenoxy)Methyl]benzeneacetic Acid
2 prices
Selected condition:
Brand
- Medical Isotopes, Inc.
- TRC
Package
- 100mg
- 1g
- ManufacturerMedical Isotopes, Inc.
- Product number47268
- Product description(αE)-α-(Methoxyimino)-2-[(2-methylphenoxy)methyl]benzeneaceticAcid
- Packaging1g
- Price$2200
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberM262705
- Product description(αE)-α-(Methoxyimino)-2-[(2-methylphenoxy)methyl]benzeneaceticAcid
- Packaging100mg
- Price$185
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Medical Isotopes, Inc. | 47268 | (αE)-α-(Methoxyimino)-2-[(2-methylphenoxy)methyl]benzeneaceticAcid | 1g | $2200 | 2021-12-16 | Buy |
TRC | M262705 | (αE)-α-(Methoxyimino)-2-[(2-methylphenoxy)methyl]benzeneaceticAcid | 100mg | $185 | 2021-12-16 | Buy |
Properties
Melting point :134-136°C
Boiling point :466.2±47.0 °C(Predicted)
Density :1.15±0.1 g/cm3(Predicted)
storage temp. :Refrigerator
solubility :DMSO (Slightly), Methanol (Slightly)
form :Solid
pka :2.83±0.41(Predicted)
color :White to Off-White
Boiling point :466.2±47.0 °C(Predicted)
Density :1.15±0.1 g/cm3(Predicted)
storage temp. :Refrigerator
solubility :DMSO (Slightly), Methanol (Slightly)
form :Solid
pka :2.83±0.41(Predicted)
color :White to Off-White
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|